Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2393487Generated: October 25, 2026

Deferoxamine → 3,4-Diacetoxy-1-butene

https://huagongshe.com/reaction/2393487

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDeferoxamineHCID 2973—
ReactantSodium HydroxideHCID 14798—
ReactantDeferoxamine MesylateHCID 62881—
ReactantIodoacetic acid N-hydroxysuccinimide esterHCID 3299230—
ReactantN-cysteinyl-biotinHCID 131720825—
SolventMethanolHCID 887—
Product3,4-Diacetoxy-1-buteneHCID 2735001—

Reaction Steps

DACB was synthesized by covalently conjugating iodoacetyl-deferoxamine and N-cysteinyl-biotin by the following Scheme II. ##STR20## Solid deferoxamine mesylate was added to methanol for a concentration of 20 mM, followed by addition of NaOH to reach a final concentration of 20 mM NaOH. The solution was heated and maintained at 65°. Solid iodoacetic acid N-hydroxysuccinimide ester (NHS-IA) was added to the deferoxamine solution to a final molarity of 50mM NHS-IA and incubated for at least one hour at 65°. The resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column using a linear gradient of 0-10 ml 100% Buffer A (0.025M phosphate, pH 6, 2 mM NTA) and 10-60 ml 0-100% Buffer B (0.025M phosphate, pH 6, 2 mM NTA, 75% methanol). IA-DFO, but not unconjugated DFO, has an absorbance at 260 nm and thus was purified by measuring the absorbance of the eluate and collecting the fraction with absorbance at 260 nm.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05807879
Source datasetuspto-grants-1998_09
ORD IDord-51bebd3a49be48da8d6c3ecbb677d478
Source noteuspto-grants-1998_09